Dr Agarwal’s Healthcare made its debut on the NSE at ₹402 per share, matching the upper end of its IPO price band of ₹382-₹402. However, the stock quickly faced selling pressure, dropping by 7.40% to ₹372.05 in early trading.
IPO Details:
- Issue Size: ₹3,027.26 crore
- Fresh Issue: 0.75 crore shares worth ₹300 crore
- Offer for Sale: 6.78 crore shares worth ₹2,727.26 crore
- Price Band: ₹382-₹402 per share
- Lot Size:
- Retail Investors: 35 shares (₹14,070 minimum investment)
- sNII: 15 lots (₹2,11,050 investment)
- bNII: 72 lots (₹10,13,040 investment)
Key Strengths of Dr Agarwal’s Healthcare:
- Largest eye care services provider in India, with a trusted brand reputation.
- Offers comprehensive, end-to-end eye care services through a scalable, asset-light hub-and-spoke model.
- Known for clinical excellence and surgical innovations, supported by an experienced clinical board.
- Led by doctor-promoters with a team of qualified medical professionals.
IPO Book-Running Lead Managers:
Kotak Mahindra Capital, Morgan Stanley India, Jefferies India, and Motilal Oswal Investment Advisors. KFin Technologies was the registrar for the issue.
Despite its robust fundamentals and market-leading position, the stock’s early performance reflects cautious investor sentiment amid market volatility.
